Chengdu Olymvax Biopharmaceuticals (SH:688319) Ge Long Hui A P P·2026-01-12 08:21Core Viewpoint - The company, Olin Bio (688319.SH), has submitted an application for the public issuance of H-shares and listing on the Hong Kong Stock Exchange on November 25, 2025, indicating a strategic move to expand its capital base and market presence [1] Group 1: Company Actions - The company has filed the necessary application materials for the issuance and listing with the China Securities Regulatory Commission (CSRC), which has recently accepted the application [1] - The application for the public issuance and listing has been published on the Hong Kong Stock Exchange's website on the same day as the submission [1] Group 2: Regulatory Approval - The issuance and listing are subject to approvals from various regulatory bodies, including the CSRC, the Securities and Futures Commission of Hong Kong, and the Hong Kong Stock Exchange, indicating that the process still carries uncertainties [1]